110467-60-2 Usage
Description
(2S)-2-[2-(4-isobutylphenyl)propanoylamino]propanoic acid is a white solid with a molecular formula of C18H23NO3. It is a derivative of the amino acid proline and is classified as a peptide. (2S)-2-[2-(4-isobutylphenyl)propanoylamino]propanoic acid is a type of prodrug, meaning it is converted into its active form in the body.
Uses
Used in Pharmaceutical Industry:
(2S)-2-[2-(4-isobutylphenyl)propanoylamino]propanoic acid is used as a nonsteroidal anti-inflammatory drug (NSAID) for its analgesic, antipyretic, and anti-inflammatory properties. It works by inhibiting the production of prostaglandins, which are responsible for causing inflammation and pain.
Used in Pain Management:
(2S)-2-[2-(4-isobutylphenyl)propanoylamino]propanoic acid is used as a pain reliever for treating various types of pain, including arthritis, menstrual cramps, and muscle aches.
Used in Fever and Inflammation Reduction:
(2S)-2-[2-(4-isobutylphenyl)propanoylamino]propanoic acid may also be prescribed for reducing fever and inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 110467-60-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,4,6 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 110467-60:
(8*1)+(7*1)+(6*0)+(5*4)+(4*6)+(3*7)+(2*6)+(1*0)=92
92 % 10 = 2
So 110467-60-2 is a valid CAS Registry Number.
110467-60-2Relevant articles and documents
Synthesis of Ibuprofen Hybrid Conjugates as Anti-Inflammatory and Analgesic Agents
-
Paragraph 0186; 0188; 0191-0192, (2021/11/26)
Disclosed herein as ibuprofen hybrid conjugates and methods of their use to reduce inflammation, pain, and fever. The ibuprofen conjugates have potent anti-inflammatory and analgesic properties with low potential for ulcerogenic activity. An exemplary com
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach
Aureli, Loretta,Cruciani, Gabriele,Cesta, Maria Candida,Anacardio, Roberto,De Simone, Lucio,Moriconi, Alessio
, p. 2469 - 2479 (2007/10/03)
A novel class of 2-(R)-phenylpropionamides has been recently reported to inhibit in vitro and in vivo interleukin-8 (CXCL8)-induced biological activities. These CXCL8 inhibitors are derivatives of phenylpropionic nonsteroidal antiinflammatory drugs (NSAID
